Get all your news in one place.
100's of premium titles.
One app.
Start reading
Reuters
Reuters
Health
Anton Zverev and Maria Tsvetkova

Up to one in 10 residents of Moscow may have had coronavirus infections: laboratory

A medical specialist takes a test for the novel coronavirus (2019-nCoV) in Hadassah clinic at the Skolkovo innovation centre on the outskirts of Moscow, Russia April 24, 2020. REUTERS/Maxim Shemetov

Tests in the wider Moscow region to see if people are carrying coronavirus antibodies suggest that as many as one in 10 residents may have been infected, a government project said on Friday.

The results, disclosed to Reuters by Moscow's International Medical Cluster, suggest that the novel coronavirus has spread more widely than the official tallies of confirmed infections.

A medical specialist holds a testing tube with blood in Hadassah clinic, which offers tests for for antibodies against the coronavirus disease (COVID-19), at the Skolkovo innovation centre on the outskirts of Moscow, Russia April 24, 2020. REUTERS/Maxim Shemetov

Moscow and the Moscow region around it has reported 44,786 confirmed cases of the virus, suggesting 0.2% of the area's population of more than 20 million has been infected.

The Moscow branch of the Israeli Haddassa Medical clinic offers tests for the presence of antibodies to people with no flu-like symptoms for 4,300 roubles ($57.70) - so its tested group is self-selecting rather than being a random sample of the population.

It has conducted about 1,000 tests in its first two weeks of the program, the International Medical Cluster said on Friday.

A medical specialist holds a positive test for the novel coronavirus (2019-nCoV) in Hadassah clinic at the Skolkovo innovation centre on the outskirts of Moscow, Russia April 24, 2020. REUTERS/Maxim Shemetov

"Last week, when the testing was launched, about 3% of people had (coronavirus) antibodies. This week, the figure rose to about 9-10%. That means that gradual immunisation is underway," it said.

The test is produced by the China-based Genrui Biotech company and certified for use in the European Economic Area, the laboratory said.

It is not yet known whether antibodies to the new coronavirus confer some level of immunity, in the way that antibodies to many other infectious diseases do.

A medical specialist wearing protective gear works in Hadassah clinic, which offers tests for antibodies against the coronavirus disease (COVID-19), at the Skolkovo innovation centre on the outskirts of Moscow, Russia April 24, 2020. REUTERS/Maxim Shemetov

Despite a partial lockdown across the country, the number of confirmed coronavirus cases rose sharply in Russia this month and surpassed 68,000 on Friday.

The results given by the International Medical Cluster on Friday follow earlier data harvested from the first trial test for COVID-19 antibodies when the authorities checked 226 samples and found 11 people had carried the disease, an infection rate of almost 5%.

(Writing by Maria Tsvetkova; Editing by Frances Kerry)

A view shows testing tubes in Hadassah clinic, which offers tests for for antibodies against the coronavirus disease (COVID-19), at the Skolkovo innovation centre on the outskirts of Moscow, Russia April 24, 2020. REUTERS/Maxim Shemetov
A medical specialist wearing protective gear works in Hadassah clinic, which offering tests for antibodies against the coronavirus disease (COVID-19), at the Skolkovo innovation centre on the outskirts of Moscow, Russia April 24, 2020. REUTERS/Maxim Shemetov
A medical specialist takes a test for the novel coronavirus (2019-nCoV) in Hadassah clinic at the Skolkovo innovation centre on the outskirts of Moscow, Russia April 24, 2020. REUTERS/Maxim Shemetov
A view shows negative tests for the novel coronavirus (2019-nCoV) in Hadassah clinic at the Skolkovo innovation centre on the outskirts of Moscow, Russia April 24, 2020. REUTERS/Maxim Shemetov
A medical specialist wearing protective gear works in Hadassah clinic, which offers tests for antibodies against the coronavirus disease (COVID-19), at the Skolkovo innovation centre on the outskirts of Moscow, Russia April 24, 2020. REUTERS/Maxim Shemetov
A view shows testing tubes in Hadassah clinic, which offers tests for for antibodies against the coronavirus disease (COVID-19), at the Skolkovo innovation centre on the outskirts of Moscow, Russia April 24, 2020. REUTERS/Maxim Shemetov
A medical specialist holds a negative test for the novel coronavirus (2019-nCoV) in Hadassah clinic at the Skolkovo innovation centre on the outskirts of Moscow, Russia April 24, 2020. REUTERS/Maxim Shemetov
A medical specialist takes a test for the novel coronavirus (2019-nCoV) in Hadassah clinic at the Skolkovo innovation centre on the outskirts of Moscow, Russia April 24, 2020. REUTERS/Maxim Shemetov
Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.